Vascular endothelial growth factor (VEGF) induces human Langerhans cell migration
β Scribed by M. J. Staquet; Sylvie Godefroy; Christelle Jacquet; Jacqueline Viac; Daniel Schmitt
- Publisher
- Springer-Verlag
- Year
- 2001
- Tongue
- English
- Weight
- 46 KB
- Volume
- 293
- Category
- Article
- ISSN
- 0340-3696
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Background. Vascular endothelial growth factor (VEGF) is a specific endothelial cell mitogen that stimulates angiogenesis and plays a crucial role in tumor growth. The aim of the present study was to evaluate the expression of VEGF and of its two high-affinity tyrosine kinase receptors (KDR and Flt-
Vascular endothelial growth factor (VECF) is a 45kDa secreted peptide that has potent mitogenic activity specific for endothelial cells in vitro and the ability to induce a strong angiogenic response in vivo. In the present study, 24 h treatment with VEGF resulted in a stimulation of expression of t
The purpose of this study was to investigate the expression of vascular endothelial growth factor (VEGF) -C in human esophageal squamous cell carcinomas to elucidate its role in lymph node metastasis and tumor progression. The expression of VEGF-C and flt-4 genes was examined in 5 esophageal carcino
## Abstract VEGF and TGFβΞ²1 induce angiogenesis but have opposing effects on endothelial cells. VEGF protects endothelial cells from apoptosis; TGFβΞ²1 induces apoptosis. We have previously shown that VEGF/VEGF receptorβ2 (VEGFR2) signaling mediates TGFβΞ²1 induction of apoptosis. This finding raised